I understand & accept & do;Entendo & aceito & faço. Estratégia pró-adesão à anticoagulação oral

Arquivos Brasileiros de Cardiologia

Volumn 82, Issue 4, 2004, Pages 309-312

  Grinberg, Max ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULATION; BLEEDING; COMORBIDITY; DOSE RESPONSE; DRUG INDICATION; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; MORTALITY; RISK BENEFIT ANALYSIS;

EID: 2442521312     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch Intern Med. 2001; 161: 1443-7.
2. Hirsh J, Dalen JE, Anderson D et al. Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1998; 114 Suppl: 445S-469S.
3. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorragic complications of anticoagulant treatment. Chest 1998; 114: 511S-523S.
4. Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest 2001; 119: 22S-38S.
5. Beyth RJ, Quinn LM, Landefeld S. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-9.
6. Vidaillet H, Granada JF, Chyou PH et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 2002; 113: 432-355.
7. Lavitola PL. Varfarina versus aspirina na prevenção de tromboembolismo em portador de doença valvar mitral reumatismal com fibrilção atrial: estudo prospectivo e randomizado. Tese de doutorado. Faculdade de Medicina Universidade de São Paulo, 2002.
8. Samsa GP, Matchar DB, Phillips DL, Mc Grann J. Which approach to anticoagulation management is best? Illustration of an interactive mathematical model to support informed decision making. J Thromb Thrombolysis 2002; 4: 103-11.
9. Ferro JM. Cardioembolic stroke: an update. Lancet Neurol 2003; 2: 177-88.
10. McAnulty JH. Barriers to the use of warfarin: potential solutions. J Interv Card Electrophysiol 2004; Suppl 10, 1: 17-20.
11. Flaker GC, McGowan DJ, Boechler M, Fortune G, Gage B. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 1999; 137: 307-12.
12. Albers GW, Yim JM, Belew KM et al. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med 1996; 156: 2311-6.
13. Lavitola PL, Spina GS, Tarasoutchi F, Sampaio RO, Nigri M, Grinberg M. Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients. Circulation 2002; 106: suppl II-526.
14. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.
15. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial. Lancet 1996; 348: 633-8.
16. Poller L, Thomson J. Evidence for "rebound" hypercoagulability after stopping anticoagulants. Lancet 1964; 2: 62-4.
17. Odén A, Fahlén M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325: 1073-5.
18. Banet GA, Waterman AD, Milligan PE, Gatchel SK, Gage BF. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio. Chest 2003; 123: 499-503.
19. Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DF. Prospective study of the outcomes on ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 2000; 160: 1612-7.
20. Sidhu P, O'Kane HO. Self-management anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery 2001; 72: 1523-7.